Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This study is designed to determine whether 6 months of anti-HIV drugs given along with
tuberculosis treatment will delay the onset of AIDS in HIV infected African patients.
Phase:
Phase 3
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)